Maria Cinta Cid
Autoimmune Diseases Department Medical InternistResearch group
- Systemic vasculitis Group leader (R4)
Featured publications
-
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis
Authors:Reference: Journal Of Allergy And Clinical Immunology 2019. -
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
Authors:Reference: Annals Of The Rheumatic Diseases 2019. -
Expression and function of IL12/23 related cytokine subunits (p35, p40, and p19) in giant-cell arteritis lesions: Contribution of p40 to Th1-and Th17-mediated inflammatory pathways
Authors:Reference: Frontiers In Immunology 2018. -
Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: A mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis
Authors:Reference: Annals Of The Rheumatic Diseases 2017. -
Trial of Tocilizumab in Giant-Cell Arteritis.
Authors:Reference: New England Journal Of Medicine 2017. -
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Authors:Reference: New England Journal Of Medicine 2017. -
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.
Authors:Reference: American Journal Of Human Genetics 2017. -
Blocking interferon gamma reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis
Authors:Reference: Annals Of The Rheumatic Diseases 2016. -
Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling
Authors:Reference: Science Signaling 2016. -
Changes in biomarkers after therapeutic intervention in temporal arteries cell arteritis
Authors:Reference: Annals Of The Rheumatic Diseases 2014.
Featured Projects
-
Perfil de expresión génica en linfocitos T CD4+ de pacientes con granulomatosis eosinofílica con poliangiítis o Sde. de Churg-Strauss
Principal investigator: Georgina Espigol-Frigole, Georgia Espigol-FrigoleFunder: Instituto de Salud Carlos III (ISCIII)Code: PI18/00461Duration: 01/07/2019 - 31/12/2021 -
Effects of blocking IL-6 receptor with tocilizumab on ex-vivo cultured arteries from patients with giant-cell arteritis. Searching for predictors of response
Principal investigator: Maria Cinta Cid XutglaFunder: International vasculitis FoundationCode: VASCFOUND_RG_18_01Duration: 01/06/2019 - 31/05/2020 -
Multi-cellular interactions in the progression of chronic inflammatory diseases and lymphoproliferative disorders: 3D models to investigate targeted immune therapies -3DIMMUNETARGET
Principal investigator: Maria Cinta Cid Xutgla, Patricia Pérez GalánFunder: Ministerio de Economia y Competitividad (MINECO)Code: SAF 2017- 88275-RDuration: 01/01/2018 - 31/12/2020 -
Development of ascending aorta dilatation and coronary aneurysms in patients with systemic vasculitis (giant-cell arteritis and Kawasaki disease respectively). Role of HIF signaling in abnormal vascular remodeling and inflammation
Principal investigator: Maria Cinta Cid XutglaFunder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundació La Marató de TV3Code: Marató TV3 2014/201507Duration: 01/01/2016 - 01/01/2018 -
Vasculitis de pequeño vaso rodeando una arteria temporal preservada: significado clínico y búsqueda de biomarcadores con utilidad diagnóstica
Principal investigator: Georgina Espigol FrigoleFunder: Instituto de Salud Carlos III (ISCIII)Code: PI15/00092Duration: 01/01/2016 - 31/07/2019